These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4992967)

  • 1. Discontinuation of chemotherapy for chronic schizophrenics.
    Prien RF; Levine J; Switalski RW
    Hosp Community Psychiatry; 1971 Jan; 22(1):4-7. PubMed ID: 4992967
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the effects of oxypertine and trifluoperazine in withdrawn schizophrenics.
    Hunt PV
    Br J Psychiatry; 1967 Dec; 113(505):1419-24. PubMed ID: 4865294
    [No Abstract]   [Full Text] [Related]  

  • 3. Pimozide: a comparative study in the treatment of chronic schizophrenic patients.
    Pinard G; Prénoveau Y; Fliesen W; Elie R; Bielmann P; Lamontagne Y; Tétreault L
    Int J Clin Pharmacol; 1972 Apr; 6(1):22-7. PubMed ID: 4558783
    [No Abstract]   [Full Text] [Related]  

  • 4. Withdrawal of maintenance drugs with long-term hospitalized mental patients: a critical review.
    Tobias LL; MacDonald ML
    Psychol Bull; 1974 Feb; 81(2):107-25. PubMed ID: 4149623
    [No Abstract]   [Full Text] [Related]  

  • 5. Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication.
    Prien RF; Cole JO; Belkin NF
    Br J Psychiatry; 1969 Jun; 115(523):679-86. PubMed ID: 5806858
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluspirilene, an injectable, and penfluridol, an oral long-acting, neuroleptic. A comparative double-blind trial in residual schizophrenia.
    Tanghe A; Vereecken JL
    Acta Psychiatr Scand; 1972; 48(4):315-31. PubMed ID: 4566564
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug responses of three hospital population samples participating in a collaborative study.
    Crane GE; Krummholz W; Lichtigfeldt FJ; Salim T
    Arzneimittelforschung; 1966 Feb; 16(2):290-3. PubMed ID: 4383294
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical effect of the tranquilizer mepiprazol in hospitalized chronic schizophrenis].
    Gonçalves N
    Psychopharmacologia; 1972; 25(3):281-90. PubMed ID: 4557942
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 10. A pilot study of pimozide in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):706-13. PubMed ID: 5000718
    [No Abstract]   [Full Text] [Related]  

  • 11. Butaperazine in chronic schizophrenic patients: a doubled-blinf study.
    Brotman RK; Muzekari LH; Shanken PM
    Curr Ther Res Clin Exp; 1969 Jan; 11(1):5-8. PubMed ID: 4387485
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial with Sulpiride and placebo in chronic schizophrenics (study of 89 patients using the Harris-Letemendía-Willems scale)].
    Mezquita Blanco J; Cubillo Sánchez J; Aizpiri Díaz J; Zubia Zubia B
    Arch Neurobiol (Madr); 1972; 35(5):453-72. PubMed ID: 4568565
    [No Abstract]   [Full Text] [Related]  

  • 13. Trazodone in the treatment of schizophrenias.
    Galvan L; Nair NP; Kussin D; Ban TA
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):776-80. PubMed ID: 4201975
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between the hospital milieu and the response to phenothiazines in the treatment of schizophrenics.
    Klerman GL; Goldberg SG; Davis D
    Acta Psychiatr Belg; 1970 Nov; 70(6):716-29. PubMed ID: 4931261
    [No Abstract]   [Full Text] [Related]  

  • 15. A year's trial of thiothixene in chronic schizophrenia.
    Angus JW; Iqbal F; Iqbal J; Simpson GM
    Int J Neuropsychiatry; 1967; 3(5):408-12. PubMed ID: 4866598
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind study of tybamate in psychotic patients.
    Meshel E; Denber HC
    Dis Nerv Syst; 1967 May; 28(5):311-3. PubMed ID: 5338174
    [No Abstract]   [Full Text] [Related]  

  • 17. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical, toxicological and electroencephalographic study with SCH-12,679 in chronic schizophrenics.
    Keskiner A; Itil TM; Han TH; Saletu B; Hsu W
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):714-25. PubMed ID: 5000719
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicentric clinical evaluation of pimozide. Preliminary report.
    Brugmans J
    Acta Neurol Psychiatr Belg; 1968; 68(12):875-87. PubMed ID: 4976735
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.